Economic Outcomes and Incidence of Postsurgical Hypotension With Liposomal Bupivacaine vs Epidural Analgesia in Abdominal Surgeries
**Background:** Epidural analgesia can be associated with high costs and postsurgical risks such as hypotension, despite its widespread use and value in providing opioid-sparing pain management. We tested the hypothesis that liposomal bupivacaine (LB) might be a reliable alternative to epidural anal...
Saved in:
Main Authors: | Margaret Holtz, Nick Liao, Jennifer H. Lin, Carl V. Asche |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2022-09-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.37739 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Digital Ischemia with Liposomal Bupivacaine
by: José Raul Soberón, et al.
Published: (2014-01-01) -
Clinical and Economic Outcomes Associated With Use of Liposomal Bupivacaine Versus Standard of Care for Management of Postsurgical Pain in Pediatric Patients Undergoing Spine Surgery
by: Robert Tracy Ballock, et al.
Published: (2021-04-01) -
Patient Complications after Interscalene Block: A Retrospective Comparison of Liposomal Bupivacaine to Nonliposomal Bupivacaine
by: Jacob L. Hutchins, et al.
Published: (2020-01-01) -
Epidural labour analgesia: A review (labour epidural)
by: George Manjit, et al.
Published: (2024-01-01) -
Recent Advances in Epidural Analgesia
by: Maria Bauer, et al.
Published: (2012-01-01)